A wall shear stress map of dilated ascending aorta along with the three...
A wall shear stress map of dilated ascending aorta along with the three analysis planes

Figures modified from Kiema M et al. Front Physiol. 2022, 7;13:934941 and Johanna Laakkonen group

News • Dissection, rupture, dilatation

Aortic stability assessment to identify high-risk patients

Prediction of aortic dissection or rupture of the thoracic aortic aneurysm is a challenge, and more accurate identification of high-risk patients and timing of repair surgery are required.

A new collaborative study by the University of Eastern Finland and Kuopio University Hospital indicates that magnetic resonance imaging-derived wall shear stress values predict pathological changes in the aortic wall in patients with ascending aortic dilatation. The findings could be used for the identification of high-risk patients in the future. The study is openly accessible in Frontiers in Physiology

In ascending aortic dilatation, the aorta progressively dilates due to the weakening of the aortic wall structure leading to the formation of an aneurysm. This can lead to severe complications, such as aortic dissection or rupture. The main risk factors for ascending aortic dilatation are the bicuspid aortic valve and certain genetic factors or syndromes. Besides surgical intervention, no effective treatment exists. Typically, patients are asymptomatic, and an aneurysm is discovered incidentally, or only when a life-threatening complication occurs. After diagnosis, aortic dilatation is monitored regularly by computed tomography or magnetic resonance imaging.

Our research aim is to identify novel molecular targets for aortic dilatation that could be used to develop their therapeutics and diagnostics

Johanna Laakkonen

Besides genetics, aortic vascular flow has been suggested to induce changes in the aortic wall structure and to contribute to disease progression. The new study from the University of Eastern Finland and Kuopio University Hospital shows for the first time the relation between wall shear stress, aortic wall strength, and site-specific cell composition in patients having ascending aortic dilatation. The results demonstrate that altered wall shear stress in patients regulates biomechanical properties, aortic degeneration, and cell-driven mechanisms. The study identifies a new molecular marker, MYH10, as an indicator of pathological changes in the aortic wall. These findings may be used for the identification of high-risk patients in the future. 

“Our research aim is to identify novel molecular targets for aortic dilatation that could be used to develop their therapeutics and diagnostics,” says Academy Research Fellow Johanna Laakkonen of the University of Eastern Finland. “We aim to identify patients with a high risk of aortic dilatation or rupture and improve the follow-up of these patients, thus reducing the risk for life-threatening complications,” says Professor Marja Hedman of the University of Eastern Finland and Kuopio University Hospital. 


Source: University of Eastern Finland

15.01.2023

Read all latest stories

Related articles

Photo

Article • Mammography supplement

Breast MRI screening for women with high-risk lesions – is it necessary?

Women with high-risk breast lesions (HRLs) and no family history of breast cancer or BRCA mutations are generally considered to be at moderate risk of developing breast cancer. Breast cancer…

Photo

News • Appeal for imaging improvements

Study reveals alarming failures in pancreatic cancer detection

Pancreatic cancer tumours are being missed on CT and MRI scans, narrowing the window for life-saving curative surgery, research presented at UEG Week 2022 has revealed.

Photo

News • CMR-ECV vs. light-chain cardiac amyloidosis

'Stiff heart syndrome': Advanced MRI benefits patients

An advanced form of cardiac MRI has for the first-time enabled clinicians to measure the effectiveness of chemotherapy in patients with the life-limiting condition ‘stiff heart syndrome’.

Related products

Accutron MR

Injector

Medtron AG · Accutron MR

MEDTRON AG
Accutron MR3

Injectors

Medtron AG · Accutron MR3

MEDTRON AG
Advanced intelligent Clear-IQ Engine for MR

Artificial Intelligence

Canon · Advanced intelligent Clear-IQ Engine for MR

Canon Medical Systems Europe B.V.
Airis Vento Plus

Open

Fujifilm · Airis Vento Plus

FUJIFILM Europe GmbH
Aperto Lucent Plus

Open

Fujifilm · Aperto Lucent Plus

FUJIFILM Europe GmbH
BI 6 Comfort Coil

MRI Coils

Noras · BI 6 Comfort Coil

Noras MRI products GmbH
Subscribe to Newsletter